Stroke-Like Migraine Attacks After Radiation Therapy (SMART) Syndrome: A Diagnostic Challenge a Decade After Cranial Irradiation
Abstract
Stroke-like migraine attacks after radiation therapy (SMART) syndrome is a rare, late complication of cranial radiotherapy characterized by recurrent neurological symptoms, which may include headaches, hemiparesis, aphasia, seizures and confusion. The condition typically manifests years after radiation exposure, with magnetic resonance imaging (MRI) showing transient, reversible cortical abnormalities in previously irradiated regions. Although often self-limiting, neurological recovery may be incomplete in some cases. We present the case of a 64-year-old elderly male with a prior history of cranial irradiation received in 2015 who was admitted with abnormal body movements. Initial blood investigations and a non-contrast CT head were unremarkable. The MRI brain scan demonstrated deep white matter ischemic changes with no new focal lesions compared to a prior scan. Cerebrospinal fluid analysis was normal. Electroencephalography revealed focal onset seizures with secondary generalization. Following neurology review, antiepileptic therapy was optimized. Based on the clinical history, radiological findings, and seizure disorder, a diagnosis of SMART syndrome was made. The patient gradually improved his level of consciousness with a decrease in seizure activity with good neurological recovery.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.